Combined, these properties make TSPAN4 a potential therapeutic target for the prevention and treatment of vascular diseases associated with VSMC proliferation, migration, and phenotypic switching, such as atherosclerosis, hypertension, restenosis after angioplasty, and diabetic vascular complications [36]. This evidence concerns the gene TSPAN4 and Hypertension.